The Senior Director of Manufacturing leads Lyell’s cell therapy manufacturing organization through the transition from clinical-stage to commercial operations. This hands-on leadership role owns GMP manufacturing execution across the product lifecycle, including facility and process readiness for BLA submission and pre-license inspection (PLI), and the development of a scalable, inspection-ready commercial manufacturing organization. The role is intended for a leader who has taken an autologous cell therapy through late-stage clinical manufacturing and into licensure and launch. The Senior Director leads manufacturing readiness for BLA filing, PLI, and commercial launch; oversees day-to-day clinical and commercial GMP manufacturing; and partners with Quality, Supply Chain, Process Development, MSAT, Regulatory, Commercial, and external partners. The position builds and mentors a high-performing manufacturing organization, contributes to Technical Operations leadership and executive planning, manages manufacturing budgets and capital projects, and supports regulatory filings and health authority interactions. Lyell is a clinical-stage company developing next-generation CAR T-cell therapies for solid tumors and hematologic malignancies. Its product candidates are designed to create T cells that resist exhaustion and retain durable stemness. Lyell describes its culture as based on Science, Respect, Collaboration, and Courage, and is committed to an open, diverse, and inclusive workplace.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior